April 17, 2025 - 19:00

European B2B payment solution provider Pliant has announced its acquisition of the Austrian InsurTech company hi.health. This strategic move, revealed on April 16, aims to enhance Pliant's offerings by integrating hi.health’s innovative insurance solutions into its portfolio.
The acquisition is expected to bolster Pliant's capabilities in the insurance market, allowing the company to provide a more comprehensive suite of services to its clients. Hi.health specializes in digital insurance solutions, which align well with Pliant's focus on streamlining payment processes for businesses.
By incorporating hi.health's technology and expertise, Pliant aims to create synergies that will enhance customer experience and improve operational efficiency. This expansion into the insurance sector reflects Pliant's commitment to diversifying its services and tapping into new growth opportunities within the financial technology landscape.
As the B2B payment industry continues to evolve, Pliant's acquisition positions the company as a key player in both the payment and insurance markets.
December 15, 2025 - 04:17
Cassidy Optimistic About Bipartisan Deal on ACA Subsidies by Year-EndSenator Bill Cassidy (R-La.) shared a hopeful outlook on the potential for a bipartisan agreement aimed at extending enhanced Affordable Care Act (ACA) subsidies for specific Americans. Speaking on...
December 14, 2025 - 05:37
Senate's Health Care Votes Fall Short: Key Points to ConsiderThe Senate this week failed to pass dueling bills from Republicans and Democrats aimed at addressing a looming spike in health insurance costs for individuals purchasing Affordable Care Act (ACA)...
December 13, 2025 - 06:07
Unveiling Inspiring Tales of Marathon Runners at the Health and Fitness ExpoDiscover the stories and excitement as runners gather at the Health and Fitness Expo for the marathon weekend. This vibrant event brings together athletes from all walks of life, each with their...
December 12, 2025 - 23:33
Health Experts Criticize Potential High-Level Warnings for COVID VaccinesThe FDA is reportedly contemplating the introduction of high-level warning labels for COVID vaccines, a decision that has sparked significant concern among health experts. Many professionals in the...